Evidence map›Paper›PMID 31705173›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

Functional impact of subthalamotomy by magnetic resonance-guided focused ultrasound in Parkinson's disease: a hybrid PET/MR study of resting-state brain metabolism.

Rafael Rodriguez-Rojas, Jose A Pineda-Pardo, Raul Martinez-Fernandez, Rosalie V Kogan, Carlos A Sanchez-Catasus, Marta Del Alamo, Frida Hernández, Lina García-Cañamaque, Klaus L Leenders, Jose A Obeso

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Safety and efficacy of unilateral focused ultrasound pallidotomy on motor complications in Parkinson's disease (PD): a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Four-Year Follow-up of [Movement disorders : official journal of the Movement Disorder Society · 2021
    Article
  13. Article
  14. Transcranial Ultrasound Innovations Ready for Broad Clinical Application.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Rafael Rodriguez-RojasCentro Integral de Neurociencias (CINAC), University Hospital HM Puerta del Sur, Madrid, Spain.
Jose A Pineda-PardoCentro Integral de Neurociencias (CINAC), University Hospital HM Puerta del Sur, Madrid, Spain.
Raul Martinez-FernandezCentro Integral de Neurociencias (CINAC), University Hospital HM Puerta del Sur, Madrid, Spain.
Rosalie V KoganDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Carlos A Sanchez-CatasusDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Marta Del AlamoCentro Integral de Neurociencias (CINAC), University Hospital HM Puerta del Sur, Madrid, Spain.
Frida HernándezCentro Integral de Neurociencias (CINAC), University Hospital HM Puerta del Sur, Madrid, Spain.
Lina García-CañamaqueDepartment of Nuclear Medicine, University Hospital HM Puerta del Sur, Madrid, Spain.
Klaus L LeendersDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Jose A ObesoCentro Integral de Neurociencias (CINAC), University Hospital HM Puerta del Sur, Madrid, Spain. jobeso.hmcinac@hmhospitales.com.
Instituto de Salud Carlos III · ESUniversity Hospital HM Puerta del Sur · ESUniversity Medical Center Groningen · NLBiomedical Research Networking Center on Neurodegenerative Diseases · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSubthalamotomy using magnetic resonance-guided focused ultrasound (MRgFUS) has become a potential treatment option for the cardinal features of Parkinson's disease (PD). The purpose of this study was to evaluate the effects of MRgFUS-subthalamotomy on brain metabolism using different scale levels.

methodsWe studied resting-state glucose metabolism in eight PD patients before and after unilateral MRgFUS-subthalamotomy using hybrid [

resultsAfter subthalamotomy, there was a significant reduction in FDG uptake in the subthalamic region, globus pallidus internus, motor and premotor cortical regions, and cingulate gyrus in the treated hemisphere, and the contralateral cerebellum (p < 0.001). Diffuse metabolic increase was found in the posterior parietal and occipital areas. Treatment also resulted in a significant decline in PDRP expression (p < 0.05), which correlated with clinical improvement in UPDRS motor scores (rho = 0.760; p = 0.002).

conclusionsMRgFUS-subthalamotomy induced metabolic alterations in distributed nodes of the motor, associative, and limbic circuits. Clinical improvement was associated with reduction in the PDRP expression. This treatment-induced modulation of the metabolic network is likely to mediate the clinical benefit achieved following MRgFUS-subthalamotomy.

Indexed as

Parkinson DiseaseBrainFluorodeoxyglucose F18HumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyFluorodeoxyglucose F18Metabolic brain networkMR-guided focused ultrasoundParkinson’s diseasePositron emission tomographySubthalamotomy

Identifiers

PMID31705173
OpenAlexW2982841478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.